Screener
Fulgent Genetics, Inc. FLGT Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $71,138 | $73,463 |
| Cost of revenue | 49,648 | 45,117 |
| Gross profit | 21,490 | 28,346 |
| Operating expenses | ||
| Research and development | 14,176 | 12,395 |
| Selling and marketing | 12,221 | 8,465 |
| General and administrative | 27,684 | 25,291 |
| Amortization of intangible assets | 2,031 | 1,990 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s total revenue?
- Fulgent Genetics, Inc. (FLGT) reported total revenue of $71.14M in Q1 2026.
- How has Fulgent Genetics, Inc.'s total revenue changed year-over-year?
- Fulgent Genetics, Inc.'s total revenue decreased by 3.2% year-over-year, from $73.46M to $71.14M.
- What is the long-term trend for Fulgent Genetics, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s total revenue has grown at a -24.5% compound annual growth rate (CAGR), from $992.58M to $322.67M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Fulgent Genetics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude